Aldo-keto Reductase Family 1 Member B10 Promotes Cell Survival by Regulating Lipid Synthesis and Eliminating Carbonyls

Abstract

Aldo-keto reductase family 1 member B10 (AKR1B10) is primarily expressed in the normal human colon and small intestine but overexpressed in liver and lung cancer. Our previous studies have shown that AKR1B10 mediates the ubiquitin-dependent degradation of acetyl-CoA carboxylase-α. In this study, we demonstrate that AKR1B10 is critical to cell survival. In human colon carcinoma cells (HCT-8) and lung carcinoma cells (NCI-H460), small-interfering RNA-induced AKR1B10 silencing resulted in caspase-3-mediated apoptosis. In these cells, the total and subspecies of cellular lipids, particularly of phospholipids, were decreased by more than 50%, concomitant with 2–3-fold increase in reactive oxygen species, mitochondrial cytochrome c efflux, and caspase-3 cleavage. AKR1B10 silencing also increased the levels of α,β-unsaturated carbonyls, leading to the 2–3-fold increase of cellular lipid peroxides. Supplementing the HCT-8 cells with palmitic acid (80 μm), the end product of fatty acid synthesis, partially rescued the apoptosis induced by AKR1B10 silencing, whereas exposing the HCT-8 cells to epalrestat, an AKR1B10 inhibitor, led to more than 2-fold elevation of the intracellular lipid peroxides, resulting in apoptosis. These data suggest that AKR1B10 affects cell survival through modulating lipid synthesis, mitochondrial function, and oxidative status, as well as carbonyl levels, being an important cell survival protein. Aldo-keto reductase family 1 member B10 (AKR1B10) is primarily expressed in the normal human colon and small intestine but overexpressed in liver and lung cancer. Our previous studies have shown that AKR1B10 mediates the ubiquitin-dependent degradation of acetyl-CoA carboxylase-α. In this study, we demonstrate that AKR1B10 is critical to cell survival. In human colon carcinoma cells (HCT-8) and lung carcinoma cells (NCI-H460), small-interfering RNA-induced AKR1B10 silencing resulted in caspase-3-mediated apoptosis. In these cells, the total and subspecies of cellular lipids, particularly of phospholipids, were decreased by more than 50%, concomitant with 2–3-fold increase in reactive oxygen species, mitochondrial cytochrome c efflux, and caspase-3 cleavage. AKR1B10 silencing also increased the levels of α,β-unsaturated carbonyls, leading to the 2–3-fold increase of cellular lipid peroxides. Supplementing the HCT-8 cells with palmitic acid (80 μm), the end product of fatty acid synthesis, partially rescued the apoptosis induced by AKR1B10 silencing, whereas exposing the HCT-8 cells to epalrestat, an AKR1B10 inhibitor, led to more than 2-fold elevation of the intracellular lipid peroxides, resulting in apoptosis. These data suggest that AKR1B10 affects cell survival through modulating lipid synthesis, mitochondrial function, and oxidative status, as well as carbonyl levels, being an important cell survival protein. Aldo-keto reductase family 1 member B10 (AKR1B10, 2The abbreviations used are: KR1B10aldo-keto reductase family 1 B10AKR1B1aldo-keto reductase family 1 B1ACCAacetyl-CoA carboxylase-αARaldose reductasesiRNAsmall-interfering RNAPBSphosphate-buffered salinePARPpoly(ADP-ribose) polymeraseCM-H2DCFDA5-(and-6)-chloromethyl-2′7′-dichlorodihydrofluorescein diacetate acetyl esterBSAbovine serum albumin. also designated aldose reductase-like-1, ARL-1) is primarily expressed in the human colon, small intestine, and adrenal gland, with a low level in the liver (1Cao D. Fan S.T. Chung S.S. J. Biol. Chem. 1998; 273: 11429-11435Abstract Full Text Full Text PDF PubMed Scopus (257) Google Scholar, 2Scuric Z. Stain S.C. Anderson W.F. Hwang J.J. Hepatology. 1998; 27: 943-950Crossref PubMed Scopus (81) Google Scholar, 3Hyndman D.J. Flynn T.G. Biochim. Biophys Acta. 1998; 1399: 198-202Crossref PubMed Scopus (88) Google Scholar). However, this protein is overexpressed in hepatocellular carcinoma, cervical cancer, lung squamous cell carcinoma, and lung adenocarcinoma in smokers, being a potential diagnostic and/or prognostic marker (1Cao D. Fan S.T. Chung S.S. J. Biol. Chem. 1998; 273: 11429-11435Abstract Full Text Full Text PDF PubMed Scopus (257) Google Scholar, 2Scuric Z. Stain S.C. Anderson W.F. Hwang J.J. Hepatology. 1998; 27: 943-950Crossref PubMed Scopus (81) Google Scholar, 4Fukumoto S. Yamauchi N. Moriguchi H. Hippo Y. Watanabe A. Shibahara J. Taniguchi H. Ishikawa S. Ito H. Yamamoto S. Iwanari H. Hironaka M. Ishikawa Y. Niki T. Sohara Y. Kodama T. Nishimura M. Fukayama M. Dosaka-Akita H. Aburatani H. Clin Cancer Res. 2005; 11: 1776-1785Crossref PubMed Scopus (249) Google Scholar, 5Yoshitake H. Takahashi M. Ishikawa H. Nojima M. Iwanari H. Watanabe A. Aburatani H. Yoshida K. Ishi K. Takamori K. Ogawa H. Hamakubo T. Kodama T. Araki Y. Int. J. Gynecol. Cancer. 2007; 17: 1300-1306Crossref PubMed Scopus (86) Google Scholar, 6Penning T.M. Clin. Cancer Res. 2005; 11: 1687-1690Crossref PubMed Scopus (88) Google Scholar). aldo-keto reductase family 1 B10 aldo-keto reductase family 1 B1 acetyl-CoA carboxylase-α aldose reductase small-interfering RNA phosphate-buffered saline poly(ADP-ribose) polymerase 5-(and-6)-chloromethyl-2′7′-dichlorodihydrofluorescein diacetate acetyl ester bovine serum albumin. The biological function of AKR1B10 in the intestine and adrenal gland, as well as its role in tumor development and progression, remains unclear. AKR1B10 is a monomeric enzyme that efficiently catalyzes the reduction to corresponding alcohols of a range of aromatic and aliphatic aldehydes and ketones, including highly electrophilic α,β-unsaturated carbonyls and antitumor drugs containing carbonyl groups, with NADPH as a co-enzyme (1Cao D. Fan S.T. Chung S.S. J. Biol. Chem. 1998; 273: 11429-11435Abstract Full Text Full Text PDF PubMed Scopus (257) Google Scholar, 7Balendiran G.K. Martin H.J. El-Hawari Y. Maser E. Chem. Biol. Interact. 2009; 178: 134-137Crossref PubMed Scopus (47) Google Scholar, 8Spite M. Baba S.P. Ahmed Y. Barski O.A. Nijhawan K. Petrash J.M. Bhatnagar A. Srivastava S. Biochem. J. 2007; 405: 95-105Crossref PubMed Scopus (84) Google Scholar, 9Martin H.J. Maser E. Chem. Biol. Interact. 2009; 178: 145-150Crossref PubMed Scopus (90) Google Scholar, 10Yan R. Zu X. Ma J. Liu Z. Adeyanju M. Cao D. Int. J. Cancer. 2007; 121: 2301-2306Crossref PubMed Scopus (125) Google Scholar, 11Zu X. Yan R. Robbins S. Krishack P.A. Liao D.F. Cao D. Toxicol. Sci. 2007; 97: 562-568Crossref PubMed Scopus (40) Google Scholar, 12Zhong L. Liu Z. Yan R. Johnson S. Zhao Y. Fang X. Cao D. Biochem. Biophys. Res. Commun. 2009; 387: 245-250Crossref PubMed Scopus (71) Google Scholar). The electrophilic carbonyls are constantly produced by lipid peroxidation, particularly in oxidative conditions, and are highly cytotoxic; through interaction with proteins, peptides, and DNA, the carbonyls cause protein dysfunction and DNA damage (breaks and mutations), resulting in mutagenesis, carcinogenesis, or apoptosis (10Yan R. Zu X. Ma J. Liu Z. Adeyanju M. Cao D. Int. J. Cancer. 2007; 121: 2301-2306Crossref PubMed Scopus (125) Google Scholar, 13Hashimoto M. Sibata T. Wasada H. Toyokuni S. Uchida K. J. Biol. Chem. 2003; 278: 5044-5051Abstract Full Text Full Text PDF PubMed Scopus (85) Google Scholar, 14Okada K. Wangpoengtrakul C. Osawa T. Toyokuni S. Tanaka K. Uchida K. J. Biol. Chem. 1999; 274: 23787-23793Abstract Full Text Full Text PDF PubMed Scopus (292) Google Scholar, 15De Bont R. van Larebeke N. Mutagenesis. 2004; 19: 169-185Crossref PubMed Scopus (732) Google Scholar, 16Eder E. Scheckenbach S. Deininger C. Hoffman C. Toxicol. Lett. 1993; 67: 87-103Crossref PubMed Scopus (104) Google Scholar, 17Choudhary S. Xiao T. Srivastava S. Zhang W. Chan L.L. Vergara L.A. Van Kuijk F.J. Ansari N.H. Toxicol. Appl. Pharmacol. 2005; 204: 122-134Crossref PubMed Scopus (88) Google Scholar, 18Berhane K. Widersten M. Engström A. Kozarich J.W. Mannervik B. Proc. Natl. Acad. Sci. U.S.A. 1994; 91: 1480-1484Crossref PubMed Scopus (390) Google Scholar, 19Hauptlorenz S. Esterbauer H. Moll W. Pümpel R. Schauenstein E. Puschendorf B. Biochem. Pharmacol. 1985; 34: 3803-3809Crossref PubMed Scopus (108) Google Scholar). AKR1B10 also shows strong enzymatic activity toward all-trans-retinal, 9-cis-retinal, and 13-cis-retinal, reducing them to the corresponding retinols, which may regulate the intracellular retinoic acid, a signaling molecule modulating cell proliferation and differentiation (6Penning T.M. Clin. Cancer Res. 2005; 11: 1687-1690Crossref PubMed Scopus (88) Google Scholar, 20Ruiz F.X. Gallego O. Ardèvol A. Moro A. Domínguez M. Alvarez S. Alvarez R. de Lera A.R. Rovira C. Fita I. Parés X. Farrés J. Chem. Biol. Interact. 2009; 178: 171-177Crossref PubMed Scopus (65) Google Scholar, 21Dragnev K.H. Rigas J.R. Dmitrovsky E. Oncologist. 2000; 5: 361-368Crossref PubMed Scopus (104) Google Scholar, 22Crosas B. Hyndman D.J. Gallego O. Martras S. Parés X. Flynn T.G. Farrés J. Biochem. J. 2003; 373: 973-979Crossref PubMed Scopus (145) Google Scholar, 23Gallego O. Ruiz F.X. Ardèvol A. Domínguez M. Alvarez R. de Lera A.R. Rovira C. Farrés J. Fita I. Parés X. Proc. Natl. Acad. Sci. U.S.A. 2007; 104: 20764-20769Crossref PubMed Scopus (152) Google Scholar). In lung cancer, AKR1B10 expression is correlated with the patient smoking history and activates procarcinogens in cigarette smoke, such as polycyclic aromatic hydrocarbons, thus involved in lung tumorigenesis (24Quinn A.M. Harvey R.G. Penning T.M. Chem. Res. Toxicol. 2008; 21: 2207-2215Crossref PubMed Scopus (70) Google Scholar, 25Li C.P. Goto A. Watanabe A. Murata K. Ota S. Niki T. Aburatani H. Fukayama M. Pathol. Res. Pract. 2008; 204: 295-304Crossref PubMed Scopus (29) Google Scholar, 26Nagaraj N.S. Beckers S. Mensah J.K. Waigel S. Vigneswaran N. Zacharias W. Toxicol. Lett. 2006; 165: 182-194Crossref PubMed Scopus (131) Google Scholar). Recent studies have shown that in breast cancer cells, AKR1B10 associates with acetyl-CoA carboxylase-α (ACCA) and blocks its ubiquitination and proteasome degradation (27Ma J. Yan R. Zu X. Cheng J.M. Rao K. Liao D.F. Cao D. J. Biol. Chem. 2008; 283: 3418-3423Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar). ACCA is a rate-limiting enzyme of de novo synthesis of long chain fatty acids, catalyzing the ATP-dependent carboxylation of acetyl-CoA to form malonyl-CoA (28Witters L.A. Widmer J. King A.N. Fassihi K. Kuhajda F. Int. J. Biochem. 1994; 26: 589-594Crossref PubMed Scopus (50) Google Scholar). Long chain fatty acids are the building blocks of biomembranes and the precursor of lipid second messengers, playing a critical role in cell growth and proliferation (29Abu-Elheiga L. Matzuk M.M. Kordari P. Oh W. Shaikenov T. Gu Z. Wakil S.J. Proc. Natl. Acad. Sci. U.S.A. 2005; 102: 12011-12016Crossref PubMed Scopus (198) Google Scholar, 30Chajès V. Cambot M. Moreau K. Lenoir G.M. Joulin V. Cancer Res. 2006; 66: 5287-5294Crossref PubMed Scopus (297) Google Scholar). Therefore, ACCA activity is tightly regulated by both metabolite-mediated allosteric mechanisms and phosphorylation-dependent mechanisms; the latter are controlled by multiple hormones, such as insulin, glucagon, and growth factors (31Haystead T.A. Hardie D.G. Biochem. J. 1986; 234: 279-284Crossref PubMed Scopus (41) Google Scholar, 32Brownsey R.W. Boone A.N. Elliott J.E. Kulpa J.E. Lee W.M. Biochem. Soc. Trans. 2006; 34: 223-227Crossref PubMed Scopus (303) Google Scholar, 33Fediuc S. Gaidhu M.P. Ceddia R.B. J. Lipid Res. 2006; 47: 412-420Abstract Full Text Full Text PDF PubMed Scopus (92) Google Scholar). ACCA activity is also regulated through physical protein-protein interaction. For instance, breast cancer 1 (BRCA1) protein associates with the ACCA and blocks its Ser79 residue from dephosphorylation (34Magnard C. Bachelier R. Vincent A. Jaquinod M. Kieffer S. Lenoir G.M. Venezia N.D. Oncogene. 2002; 21: 6729-6739Crossref PubMed Scopus (82) Google Scholar, 35Moreau K. Dizin E. Ray H. Luquain C. Lefai E. Foufelle F. Billaud M. Lenoir G.M. Venezia N.D. J. Biol. Chem. 2006; 281: 3172-3181Abstract Full Text Full Text PDF PubMed Scopus (108) Google Scholar). The AKR1B10-mediated regulation on ACCA stability represents a novel regulatory mechanism, and this current study elucidated the biological significance of this regulation. The results show that AKR1B10 promotes cell survival via modulating lipid synthesis, mitochondrial function and oxidative stress, and carbonyl levels.